Search results
The Bruins’ survival, the Maple Leafs’ heartbreak, and other final thoughts from an absurd...
The Boston Globe· 3 hours agoTied at 1-1 entering OT Saturday night, the Leafs chose an inopportune time for their five skaters...
A little-understood sleep disorder affects millions and has clear links to dementia – 4 questions...
The Conversation via Yahoo News· 7 hours agoThe disease mechanism is not well understood. In some cases of REM sleep behavior disorder, a clear...
Trump Is Now Raging at His Own Lawyer—and Wrecking a Big MAGA Fantasy
The New Republic via Yahoo News· 4 days agoTrump also promoted a video of Fox’s Jeanine Pirro insisting that it showcases his ability to...
Earnings call: Harmony Biosciences maintains strong growth, eyes future launches By Investing.com
Investing.com· 5 days agoHarmony Biosciences (ticker: HRMY) has reported a solid start to the year with a 30% increase in...
Alkermes plc Reports First Quarter 2024 Financial Results
WKBN 27 Youngstown· 4 days agoAlkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2024. With these new data now in hand, we plan to initiate a phase 2 study in narcolepsy type 2 in the second half of 2024.
Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 days agoOur commercial business is strong and Wakix continues to demonstrate durable growth now year five in...
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 3 days agoRecent Updates Last month, Alkermes announced positive top-line data from a phase Ib study...
Earnings call: Alkermes reports solid Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 4 days agoThe neuroscience company reported net sales for VIVITROL at $97.7 million, ARISTADA at $78.9...
Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street...
Benzinga via AOL· 5 days agoTuesday, Harmony Biosciences (NASDAQ:HRMY) announced the acquisition of Epygenix Therapeutics,...
Needham raises Harmony Biosciences stock target on growth strategy By Investing.com
Investing.com· 4 days ago(NASDAQ: NASDAQ:HRMY) to $52, up from the previous $50, while maintaining a Buy rating on the stock....